Presented by: Magdalena Cerdá, DrPH, MPH
Presentation title: Understanding the Short- and Long-term Effects of the COVID-19 Pandemic on the Overdose Crisis
Opioid-related overdose increased sharply during the COVID-19 pandemic highlighting the need to understand the impact of Big Events on overdose and the types of policy measures that can prevent similar increases from future events. In this presentation, Dr. Cerdá will present the methods her team will use on a newly funded study to explore the COVID-19 pandemic and its effects on overdose and related outcomes; identify policy responses to COVID-19 that affected individual-level overdose risk; and examine how the pandemic’s impact on overdose risk varied across communities and populations.
Magdalena Cerdá is a Professor and Director of the Center for Opioid Epidemiology and Policy, at the Department of Population Health at NYU Grossman School of Medicine. She obtained her doctorate from the Harvard University School of Public Health in 2006, and is a former Robert Wood Johnson Health and Society Scholar. Her research focuses on the effects that state and national drug and health policies have on substance abuse trends, and on the ways the urban context shapes violence. Current funded research focuses on the impact that cannabis laws and opioid policies have on substance abuse, mental illness, and associated health problems in the United States and South America. In addition, she is evaluating the impact that firearm disqualifications based on mental illness and substance abuse criteria could have on population-level rates of firearm-related mortality.
Presented by: Dustin T. Duncan, ScD
Presentation title: Planning the Next Year of CDUHR Pilot Project and Mentoring (PPM) Core Programming
In this session, Dustin Duncan will review the services offered by the PPM Core. New, early stage, and early career investigators are strongly encouraged to attend to ask questions and to make suggestions about services and workshops offered by the Core.
Dustin T. Duncan, ScD is Associate Dean for Health Equity Research and Associate Professor in the Department of Epidemiology at Columbia University’s Mailman School of Public Health, where he directs the Columbia Spatial Epidemiology Lab and co-directs the department’s Social and Spatial Epidemiology Unit. Dr. Duncan is a Social and Spatial Epidemiologist, studying how specific neighborhood characteristics influence population health and health disparities. His research has a strong domestic (U.S.) focus, but recent work is beginning to span across the globe (including studies in Paris and London).
Dr. Duncan’s work appears in leading public health, epidemiology, medical, geography, criminology, demography, and psychology journals. Working in collaborations with scholars across the world, Dr. Duncan has over 200 high-impact articles (>120 first or senior-authored), book chapters and books cited over 9,200 times; Dr. Duncan’s research has appeared in major media outlets including U.S. News & World Report, The Washington Post, The New York Times and CNN. Dr. Duncan’s work has been funded by the National Institutes of Health, the Centers for Disease Control and Prevention, the HIV Prevention Trials Network, the Robert Wood Johnson Foundation, the Verizon Foundation, and the Aetna Foundation.
Presented by: Aria Crump, ScD
Presentation title: Practicing Resilience
Science is an exciting, challenging, and rewarding career choice, particularly when your work is in the service of human health. Despite this, early career scientists must master new skills, build reliable professional networks, and make pivotal career decisions, all while navigating personal lives and family obligations. The stress of these challenges often taxes the mental well-being of scholars. Dr. Crump will introduce the concept of resilience as a practice and discuss why it is so critical for junior investigators to know themselves and be their own best advocate.
Aria Davis Crump, ScD is currently the Director of NIDA’s Office of Diversity and Health Disparities, and the Deputy Director of NIDA’s Office of Research Training, Diversity, and Disparities. She transitioned into this role in 2023 after acting as a Health Scientist Administrator and as the Deputy Branch Chief in NIDA’s Prevention Research Branch. She is trained as a behavioral scientist and public health professional specializing in the social, cognitive, and developmental aspects of risk-taking in adolescence and applications to preventive interventions. Dr. Crump received her doctoral degree from the Johns Hopkins University Bloomberg School of Public Health, and completed postdoctoral studies in prevention research at the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Throughout her career, she has been dedicated to promoting prevention science, empowering the next generation of NIH researchers, advancing health equity, and supporting diversity in the research workforce.
Presented by: David Perlman, MD; Sam Friedman, PhD, Tetyana Vasylyeva, MSc, MPH, DPhil; Tim Rhodes, PhD
Presentation title: Big Events: Approaches to Studying and Reinvigorating HIV Prevention and Care for People Who Use Drugs in the Midst of Societal Disruption
Recent history has shown that gains in HIV elimination among people who use drugs are susceptible to erosion by large-scale, sudden onset “Big Events” that interrupt access to services and alter substance use networks, patterns, and practices. Environmental disasters, economic crises, wars and conflicts, and pandemics are examples of Big Events that have disrupted HIV, HCV, and substance use disorder (SUD) prevention and treatment, and sometimes lead new populations to use drugs. In this first of a series of symposia and other events, we will provide examples of how Big Events have changed the course of the HIV, HCV, and substance use epidemics and of how research on these changes has been conducted.
David Perlman (start at 2:56)
Sam Friedman (start at 46:40)
Tetyana Vasylyeva (start at 1:35:45)
Tim Rhodes (start at 2:22:18)
Big Events: What They are and Their Relevance to the HIV/HCV and Substance Use Epidemics
David Perlman, MD
Director, CDUHR Infectious Disease Epidemiology and Social-behavioral Theory Core
Professor of Medicine, Mount Sinai Health System Icahn School of Medicine
Historical and Theoretical Roots of the Big Events Framework for Studying Epidemics
Sam Friedman, PhD
Associate Director & Senior Theoretician, CDUHR Infectious Disease Epidemiology and Social-behavioral Theory Core
Research Professor, NYU Grossman School of Medicine
Applying the Big Events Framework: HIV and Stigma Research During the War on Ukraine
Tetyana Vasylyeva, MSc, MPH, DPhil
Assistant Professor, University of California, Irvine
Tim Rhodes, PhD
Professor, London School of Hygiene & Tropical Medicine
Holly Hagan, PhD
Professor Emerita, NYU School of Global Public Health
Presented by: Ellenie Tuazon, MPH & Alex Harocopos, PhD MSc
Presentation title: New York City 2022 Overdose Mortality Data
Recent data from the New York City Department of Health and Mental Hygiene (DOHMH) demonstrates that the overdose epidemic continues to worsen in NYC, with older Black New Yorkers experiencing the highest rates of overdose in the city. New data indicating the setting of overdose show that approximately seven out of ten overdoses occurred in a private setting; however, overdoses in public outdoor settings have also increased in recent years.
NYC’s 2022 overdose mortality data will be presented and highlight responses implemented by the Health Department to help inform efforts to reduce overdose deaths, and discuss what more can be done to ensure that New Yorkers get the information and support they need to mitigate overdose risk.
Presented by: Wiley Jenkins, PhD, MPH, FACE
Presentation title: Variation in HIV Risk Behaviors Among People Who Use Drugs in Rural US Communities
The opioid and drug use epidemic continues to evolve and expand. While the proportion of new HIV cases attributable to drug injection is increasing, it remains relatively modest in comparison to sexual transmission. Drawing data from the 8-site Rural Opioid Initiative which recruited rural people who use drugs (PWUD) across 10 states, we found significant variation in the frequency of drug use and sexual behaviors associated with infectious disease transmission and their association with participant characteristics such as age, race, and sexual orientation.
Wiley Jenkins graduated with a double major in chemistry and biology in 1991 and entered the laboratory workforce at Washington University School of Medicine. This was soon followed by 13 years in the Illinois Department of Public Health laboratories where he began as an environmental chemist and eventually became both state laboratory bioterrorism coordinator and laboratory operations manager. During this time, he also received a CDC scholarship for graduate studies at Tulane University and earned his MPH. He was then accepted into the doctoral program at the University of Illinois at Chicago and received his PhD in 2007. With this experience, he joined the SIU Department of Family and Community Medicine as research director. He was appointed Science Director for SIU Medicine’s newly created Office of Population Science and Policy in 2016 and transitioned to Chief of Epidemiology and Biostatistics when the office transitioned to the full academic Department of Population Science and Policy, where he also serves as the Interim Chair.
Presented by: Gavin Bart, MD, PhD, FACP, DFASAM
Presentation title: Fentanyl and Xylazine: Challenging the Treatment Paradigm
Gavin Bart is Director of the Division of Addiction Medicine at Hennepin Healthcare and Professor of Medicine at the University of Minnesota Medical School. He received his MD from the University of Minnesota and trained in internal medicine at the Hennepin County Medical Center. His PhD is in experimental and clinical pharmacology, also from the University of Minnesota. His areas of expertise include clinical pharmacology and the pharmacological management of opioid use disorders. His current research areas include the population pharmacokinetics of methadone, genetic influences of methadone pharmacology and treatment outcome, and implementation of opioid use disorder treatment in hospital and primary care settings. He is PI of NorthStar Node of the NIDA National Drug Abuse Treatment Clinical Trials Network and has provided extensive international technical assistance including to the PEPFAR/Substance Abuse and Mental Health Services Administration’s capacity building HIV and addiction efforts in Vietnam and South East Asia and the US Bureau of International Narcotics and Law Enforcement Affairs’ effort to develop international technology transfer centers for addiction prevention and treatment.
Presented by: Skyler Jackson, Justin Knox, Diana Sheehan, Suzan Walters, Lindsey Friend & Dustin Duncan
Presentation title: Constructing and Securing an NIH K Award
Skyler Jackson is an Assistant Professor of Public Health at Yale University who conducts research focusing on the ways individuals’ social identities (e.g., race, gender, sexual orientation) shape their everyday lives and influence health and well-being. In particular, he is interested in how experiences of stigma—if not adequately coped with—interfere with psychological functioning and contribute to health disparities. Supporting his research, Dr. Jackson has received an NIMH K01 entitled, “Intersectional stigma, mental health, and HIV risk among US GBM of color”.
Justin Knox is an Assistant Professor of Clinical Implementation Science and Intervention (in Psychiatry) at Columbia University. His research focuses on HIV and substance use among racial and sexual minorities, both domestically and globally. He is the PI of a K01 award to develop and evaluate an intervention that aims to improve HIV treatment outcomes and reduce alcohol use in heavy-drinking Black MSM.
Diana Sheehan is an Associate Professor in the Department of Epidemiology at the Robert Stempel College of Public Health and Social Work at Florida International University (FIU). She aims to contribute to health equity among the Latino population via epidemiologic studies that identify disparities along the HIV care continuum and via the design and testing of evidence-based interventions. Her current K01 examines how daily substance use, psychosocial factors, and activity spaces affect ART adherence and develops the groundwork for a just-in-time adaptive intervention to improve ART adherence.
Suzan Walters is an Assistant Professor in the Division of Epidemiology in the Department of Population Health at the NYU Grossman School of Medicine and an affiliated researcher at CDUHR. Her current K01 grant focuses on how intersectional stigma experiences affect health outcomes among people who use drugs. She has worked as an ethnographer for the National HIV Behavioral Surveillance System, a program director for the Center for the Study of Men and Masculinities, and a research fellow for AIDS Foundation Chicago.
Lindsey Friend is a Research Training and Career Development Program Officer (Health Science Administrator) in the Office of Research Training, Diversity, and Health Disparities at the National institute on Drug Abuse (NIDA). Her priority is to assist NIDA’s extramural research training and career development programs. Lindsey received her doctorate in neuroscience from Brigham Young University where she studied cocaine and cannabinoid effects on reward circuitry. She did a postdoctoral fellowship at the National Institute of Child Health and Human Development studying glutamate receptor physiology before joining NIDA in 2020.
Dustin T. Duncan is the Director of the CDUHR Pilot Projects and Mentoring Core and is an Associate Professor in the Department of Epidemiology at Columbia University’s Mailman School of Public Health, where he directs the Columbia Spatial Epidemiology Lab and co-directs the department’s Social and Spatial Epidemiology Unit. Dr. Duncan is a Social and Spatial Epidemiologist, studying how specific neighborhood characteristics influence population health and health disparities.
Presented by: Jae Sevelius, PhD
Presentation title: Designing Interventions for Impact: Community-driven Approaches to Addressing Health Inequities among Transgender Communities
How do we move from formative work and observational studies documenting health inequities to designing, testing, and implementing interventions?, Dr. Sevelius will share their approach to building a program of community-engaged research to improve health outcomes among transgender and gender expansive communities. This approach includes iterative needs assessments, intervention development and testing, and capacity building with communities that experience marginalization and the organizations that serve them.Jae Sevelius (they/them), is a Clinical Psychologist, Professor of Medical Psychology (in Psychiatry) at Columbia University, and a Research Scientist at New York State Psychiatric Institute. Dr. Sevelius’ research focuses on the role of gender affirmation in mental health and HIV-related health outcomes among transgender and gender expansive people. They work in collaboration with community-led research teams to develop and evaluate trauma-informed, gender-affirming health promotion interventions for transgender and gender expansive people in the United States and Brazil. Dr. Sevelius also specializes in psychedelic-assisted therapy for identity-based trauma and holds a Certificate in Psychedelic-Assisted Therapies and Research from the California Institute of Integral Studies. Dr. Sevelius’ research has been funded by the National Institutes of Health, the Centers for Disease Control and Prevention, the California HIV/AIDS Research Program, as well as other public institutions and private foundations.
Presented by: Caroline Dorsen, PhD, FNP-BC, FAAN
Presentation title: Psychedelics: Possibilities and Controversies
Link to Video
Psychedelics are suddenly everywhere and are being touted as miracle cures for everything from trauma to headaches. With FDA approval of MDMA and psilocybin expected in the next year, this presentation will briefly review where we are in psychedelic research, how we got here, and what issues researchers and clinicians should be aware of moving forward. Particular attention will be paid to big-picture social justice issues, including equity and access, climate justice, racial and queer justice, and indigenous rights.
Caroline Dorsen, PhD, FNP-BC, FAAN (she/her) is Associate Dean for Clinical Partnerships at Rutgers University School of Nursing, where she is on the faculty of both the schools of nursing and public health. She is a scholar, educator, and family nurse practitioner whose passion is the intersection of health and social justice. For over 15 years her research, teaching and advocacy work has largely focused on the role of stigma, bias and discrimination in substance use and LGBTQ+ health disparities. Her current project is examining nurses’ attitudes towards psychedelic drug use as a healing modality.
Presented by: Mbabazi Kariisa, PhD, MPH & Liz Rivera Blanco, MD
Presentation title: Trends and Characteristics of Xylazine Detection in Drug Overdose Deaths and Clinical Considerations
Link to Video
This presentation will provide an overview of the epidemiology of fentanyl-involved overdoses with xylazine detected and/ or co-involved. In addition, Drs. Kariisa and Rivera Blanco will discuss xylazine’s mechanism of action, background, clinical presentation, overdose and withdrawal management, and chronic use complications.
Dr. Mbabazi Kariisa is a Health Scientist in the Division of Overdose Prevention in CDC’s National Center for Injury Prevention and Control and serves as a science officer focusing on mortality-related activities for CDC’s Overdose Data to Action program. Her work focuses mainly on drug overdose death surveillance and analysis of data from the State Unintentional Drug Overdose Reporting System (SUDORS). Prior to joining NCIPC, she worked as an injury epidemiologist for the Ohio Department of Health in Columbus, Ohio where she focused on an array of injury-related topics. Dr. Kariisa received her PhD in Epidemiology from The Ohio State University and an MPH in International Health from the University of Michigan.
Dr. Liz Rivera Blanco is a Medical Toxicology Fellow from the Emory University/ CDC program, currently working in the Division of Overdose Prevention in CDC’s National Center for Injury Prevention and Control (NCIPC). Prior to joining DOP/NCIPC, she completed a 3- year residency in Emergency Medicine at St. Luke’s Episcopal Medical Center Ponce, Puerto Rico and medical school at Universidad Autonoma de Guadalajara in Mexico.